Cornea News and Research

RSS

Google Gemini and Bard pass the ophthalmology board examination

The performance of two AI chatbots in the ophthalmology board examination.

16 Apr 2024

Naturally-occurring material is an effective disinfectant for contact lenses, study suggests

A new study suggests a naturally-occurring material is an effective disinfectant for contact lenses, worn by millions of people worldwide.

7 Feb 2024

Researchers develop new method to study liver function and disease

Researchers at Karolinska Institutet in Sweden have developed a method to study liver function and disease without requiring invasive procedures.

1 Feb 2024

EU initiative develops advanced diagnostics with light and AI

Led by the UPC's Centre for Sensors, Instruments and Systems Development, an international consortium of universities, hospitals and companies is developing new technologies based on light and AI to improve the diagnosis of several diseases.

25 Jan 2024

StemSight and ERS Genomics focus on collaboration

License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness.

17 Jan 2024

Contact lenses monitor eye pressure for glaucoma prevention

Glaucoma effects around 70 million people worldwide and can cause irreversible loss of vision if not treated – but around half of those living with the condition are not aware of it.

16 Jan 2024

MADE-up or real? Review debunks severity of mask-associated dry eye syndrome

A review in the journal Eye finds that prolonged face mask use during the COVID-19 pandemic may cause mild ocular irritation, but serious eye complications are unlikely.

9 Jan 2024

Mapping tiny corneal nerves to untangle ocular mysteries

Consider the cornea if you will – and most people won't unless they're having a problem. It is the transparent front surface of the eye which allows vision by focusing light as it enters.

3 Jan 2024

Study identifies α-MSH as therapeutic candidate for corneal endothelial disease

Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.

2 Jan 2024

Machine learning predicts the long-term future of shortsighted eyes

Machine learning has been found to predict well the outcomes of many health conditions. Now, researchers from Japan have found a way to predict whether people with severe shortsightedness will have good or bad vision in the future.

13 Dec 2023

NYU Langone Health performs the world's first whole-eye and partial-face transplant for military veteran

A surgical team from NYU Langone Health performed the world's first whole-eye and partial-face transplant for a 46-year-old military veteran from Arkansas who survived a work-related high-voltage electrical accident.

9 Nov 2023

New drug candidate found to be highly effective in treating rare sight-threatening eye infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

26 Oct 2023

Let’s have an honest conversation about what to expect as you age

How many of us have wanted a reliable, evidence-based guide to aging that explains how our bodies and minds change as we grow older and how to adapt to those differences?

20 Oct 2023

Stanford Medicine researchers find new way to measure ocular aging

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.

19 Oct 2023

Microscale device for eye implantation may be used in the treatment of diabetes

Researchers in Sweden have developed a microscale device for implantation in the eye, which presents new opportunities for cell-based treatment of diabetes and other diseases.

18 Oct 2023

Phase I trial shows positive results for stem cell treatment in patients with major cornea injuries

A team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation (CALEC), which was found to be safe and well-tolerated over the short term in four patients with significant chemical burns in one eye.

18 Aug 2023

Biomimetic materials pulsed with low-energy blue light can reshape damaged corneas

An injectable biomaterial activated by pulses of low-energy blue light has tremendous potential for on-the-spot repair to the domed outer layer of the eye, a team of University of Ottawa researchers and their collaborators have revealed.

26 Jul 2023

Discovery redefines current understanding of immune cell landscape in the human cornea

University of Melbourne researchers have discovered that the sentinels guarding the healthy human cornea from pathogens and inflammation are T cells, and not another type of immune cells called dendritic cells, as previously thought.

24 Jul 2023

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

10 Jul 2023

Study unlocks the healing power of oral keratinocytes

Scientists have made significant progress in understanding the signals involved in regulating oral keratinocyte cell motility and proliferative capacity, offering new insights into potential pharmacological manipulation for regenerative medicine.

29 Jun 2023